Cost-Effective Use of Nevirapine to Prevent Vertical HIV Transmission in Sub-Saharan Africa
- 1 August 2000
- journal article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 24 (4) , 369-377
- https://doi.org/10.1097/00042560-200008010-00012
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Adherence to antiretroviral therapy by pregnant women infected with human immunodeficiency virus: a pharmacy claims-based analysisObstetrics & Gynecology, 2000
- Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan AfricaThe Lancet, 1999
- Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trialThe Lancet, 1999
- Effects of HIV counseling and testing on sexual risk behavior: a meta-analytic review of published research, 1985-1997.American Journal of Public Health, 1999
- Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d'Ivoire: a randomised trialThe Lancet, 1999
- 6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d'Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trialThe Lancet, 1999
- Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trialThe Lancet, 1999
- Attitude of pregnant women towards HIV testing in Abidjan, Côte dʼIvoire and Bobo-Dioulasso, Burkina FasoAIDS, 1998
- Field evaluation of rapid HIV serologic tests for screening and confirming HIV-1 infection in HondurasAIDS, 1997
- Zidovudine use to reduce perinatal HIV type 1 transmission in an urban medical centerPublished by American Medical Association (AMA) ,1996